Karolinska Mammography Project for Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

Karolinska Mammography Projectfor Risk Prediction of Breast Cancer

The KARMA study is supported by the Märit and Hans Rausing Initiative Against Breast Cancer, the Swedish Research Council, the Swedish Cancer Society, the Kamprad Foundation, and Stockholm County Council.

2018-09-10

First participants enrolled in the Karma CREME-1 study

The Karma CREME-1 phase 2 clinical trial on topical endoxifen for preventive treatment of women with mammographic breast density is now open for inclusion. The study will include 90 participants and each participant will use topical endoxifen for six months. Preliminary results are expected during spring 2019.